Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Major shareholding announcement


Posted on: 13 Aug 18

Company announcement
23 August 2018





Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces to have received a major shareholder announcement from Glaxo Group Limited.

Glaxo Group Limited has informed NeuroSearch that Glaxo Group Limited disposed of all of its shares in NeuroSearch following which Glaxo Group Limited does not hold any shares or voting rights in NeuroSearch.


Contact
Allan Andersen, CEO, mobile telephone 4016 3864.


About NeuroSearch
NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.

Attachment

GlobeNewswire
globenewswire.com

Last updated on: 23/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.